Active substance
Results for the substance upadacitinib
3 results
About this active substance
Upadacitinib is a medication used in the treatment of chronic inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, and atopic dermatitis. It belongs to the class of Janus kinase (JAK) inhibitors, acting by blocking the activity of JAK enzymes involved in inflammatory processes.
Upadacitinib is administered orally in tablet form, and the dosage is determined by the physician based on the condition being treated and the patient's response to therapy.
Common side effects include nausea, headache, upper respiratory tract infections, and elevated liver enzyme levels. In rare cases, severe infections, thrombosis, or other complications may occur. It is important for patients to be regularly monitored during treatment.
Upadacitinib is an effective therapeutic option for patients with chronic inflammatory diseases, helping to reduce symptoms and improve their quality of life.
Upadacitinib is administered orally in tablet form, and the dosage is determined by the physician based on the condition being treated and the patient's response to therapy.
Common side effects include nausea, headache, upper respiratory tract infections, and elevated liver enzyme levels. In rare cases, severe infections, thrombosis, or other complications may occur. It is important for patients to be regularly monitored during treatment.
Upadacitinib is an effective therapeutic option for patients with chronic inflammatory diseases, helping to reduce symptoms and improve their quality of life.
-
-
RINVOQ 30mg prolonged-release tablets ABBVIE ORIGINAL MEDICINE
-
RINVOQ 15mg prolonged-release tablets ABBVIE ORIGINAL MEDICINE